Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Loans and Notes Receivables Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares Issued Shares Outstanding Shares Outstanding Short-Term Debt repayments

Ratios

Terns Pharmaceuticals (TERN) Shares Issued (2020 - 2023)

Terns Pharmaceuticals' Shares Issued history spans 3 years, with the latest figure at $142000.0 for Q4 2023.

For Q4 2023, Shares Issued changed N/A year-over-year to $142000.0; the TTM value through Dec 2023 reached $169000.0, changed N/A, while the annual FY2025 figure was $513000.0, 17.66% down from the prior year.
Shares Issued reached $142000.0 in Q4 2023 per TERN's latest filing, up from $27000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $136.4 million in Q1 2021 to a low of -$135.5 million in Q3 2021.
Average Shares Issued over 3 years is $22.8 million, with a median of $131000.0 recorded in 2020.
The largest YoY upside for Shares Issued was 112786.67% in 2021 against a maximum downside of 112786.67% in 2021.
A 3-year view of Shares Issued shows it stood at $120000.0 in 2020, then skyrocketed by 112786.67% to $135.5 million in 2021, then crashed by 99.9% to $142000.0 in 2023.
Per Business Quant, the three most recent readings for TERN's Shares Issued are $142000.0 (Q4 2023), $27000.0 (Q3 2023), and $135.5 million (Q4 2021).